Joined the BIE Board as a Non-Executive Director in 2025.

Matthew is a molecular biophysicist and virologist by training, holding a BSc (Hons) in Molecular Biophysics from King’s College London and an MPhil in Medical Science from the University of Cambridge. His commercial and strategic roles in leading life sciences companies over the last 20 years have equipped Matthew with a multidisciplinary expertise in developing and commercialising innovations across pharmaceuticals, biotechnology, and medical devices. As Global Product Manager for GE Healthcare (now part of Danaher) he oversaw a portfolio enabling drug discovery, development, and production. He is currently the Chief Executive Officer of Hygenica MedTech, a venture-backed business addressing the global public health challenges of hospital-acquired infections and antimicrobial resistance (AMR).